glp-1 inhibitors How Receptor Agonists Evolved from Diabetes Treatments to Weight Loss Treatments GLP-1 Receptor Agonist Shortage: Challenges

Here, we report the design and target validation of EP45, a chimeric dual agonist peptide that has the surprising ability to act as an agonist at both the glucagon-like peptide-1 receptor (GLP-1R) and the neuropeptide Y 2 receptor (NPY2R)

J Cell Physiol 181: 470-478, 1999

Over the course of this interview, she shares how she evaluates peptides, why gut function is foundational to hormone optimization, how she approaches GLP1 microdosing, and what she watches for in long-term care

Drugs of Today

This often includes depositions of expert witnesses, which can be crucial in establishing the link between Ozempic and vision damage